REQUEST A DEMO
Total
USD $0.00
Search more companies

Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Main Activity of the Company is manufacturing pharmaceutical , Types of chemical drugs,Pharmaceutical Raw Material producer ,Herbal Medicine and Mineral and Animal Medicines.
The Company was established as Private joint stock companyunder name PRODUCTION OF ALBORZ SAZEH PHARMACEUTICAL MATERIALS company and was registered under Registration number 182565 on 7 January 2002 .
The Company started it s activity on 11 May 2005.
The company changed it s legal form to be public joint stock company on 24 September 2014 .
The Company Changed it s Name to be Alborz Bulk pharmaceutical manufacturer Company public joint stock on 3 January 2005.
The company listed in iran fara bourse on 25 October 2014.
The company changed it s year end on 2020-20-12 from 19/3 to be 20/12 .
The amount of medication used and the duration of treatment with the drug are documented in the prescription. When buying or using a drug, it is important to note the expiry date and the environment in which the drug is stored.
Types of medications
Herbal Medicines:
As its name implies, the origin of this drug is herbal and is found in nature. Of course, it should be prescribed by the person who is known to be herbal remedies; otherwise, it will not only improve the illness but also affect the patient.
An example of a variety of herbs are:
Willow (natural housing), yeast (constipation), grape seed (fitness), fennel (slimming), frankincense (cancer treatment), chicory sweat (useful for the liver), thyme (fissuring) and …
Mineral and Animal Medicines:
These drugs have an animal origin, such as an asshole to relieve pain, an amber smell of nasara (a female spatula) to remove environmental microbes, and in some cases to treat vaginal and hemorrhoids, wolf stools (cure pain), spider bladder (bladder bleeding ), Scorpion or scallop oil (earache treatment) and …
chemical drugs:
All drugs available to the public are produced by pharmaceutical chemists in laboratories and used in the treatment of various diseases. However, the symptoms of a type of disease are not the same in different individuals, and the drugs should be prescribed with the doctor's opinion and diagnosis.
Types of chemical drugs:
Folic acid: Useful for the health of the nervous system.
Minoxidil: Useful for the treatment of hair loss, of course, affects Master's use.
Gelofen, ibuprofen: Strong pain to relieve pain
Multivitamins: Vitamin supplements and minerals required by the human body. However, their arbitrary and high intake increases the body's need for these supplements, and other consumables can not compensate for the deficiency of vitamins in the body.
Antibiotics: Antimicrobials, such as arthromycin, amoxicillin and cefixin, are among the most widely used antibiotics.
An example of the side effects of chemical drugs
The use of sedative medicines, corticosteroids and cardiac medications without prescribing physicians and arbitrarily and continuously to complete the course of treatment, in addition to the adverse effects of the drug, can damage the eye and, as a result of non-controlled intake, is likely to cause a person to cataract.
Mission
Alborz Balk Company is active in promoting the health of the community by supplying a variety of high quality pharmaceutical ingredients for the treatment of diseases. In pursuit of its mission, the company focuses on the needs of all its stakeholders (shareholders, customers, employees, partners, suppliers and society).
view
Alborz Balk Company is a pioneer in the pharmaceutical synthesis industry and will be among the top two pharmaceutical companies in the next five years, relying on its expert and creative human resources, and will work to achieve it. The company also aims to become the most profitable company in this field.

Legal Address
Enghelab St,Nejatollahi St, No 2,Floor 2, The Unit 4.5.6
Tehran; Tehran; Postal Code: 1599914713

Contact Details: Purchase the Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock report to view the information.

Website: http://www.alborzbulk.com

Basic Information
Total Employees:
Purchase the Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock report to view the information.
Incorporation Date:
2002
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chairperson of the Executive Comittee
Ownership Details
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Alborz Bulk Pharmaceutical Manufacturer Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
135.73%
Total operating revenue
140.04%
Operating profit (EBIT)
90.19%
EBITDA
83.69%
Net Profit (Loss) for the Period
42.8%
Total assets
60.87%
Total equity
32.15%
Operating Profit Margin (ROS)
-7.15%
Net Profit Margin
-9.24%
Return on Equity (ROE)
3.8%
Debt to Equity Ratio
72.93%
Quick Ratio
-0.15%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?